<html><head><link rel="stylesheet" type="text/css" href="usc.css"/><title>U.S.C. Title 42 - THE PUBLIC HEALTH AND WELFARE</title></head><body>
<span style="font-weight:bold;font-size:12pt;">42 U.S.C. </span><br/>
<span style="font-size:10pt">United States Code, 2011 Edition</span><br/>
<span style="font-size:10pt">Title 42 - THE PUBLIC HEALTH AND WELFARE</span><br/>
<span style="font-size:10pt">CHAPTER 6A - PUBLIC HEALTH SERVICE</span><br/>
<span style="font-size:10pt">SUBCHAPTER III - NATIONAL RESEARCH INSTITUTES</span><br/>
<span style="font-size:10pt">Part A - National Institutes of Health</span><br/>
<span style="font-size:10pt">Sec. 283 - Biennial reports of Director of NIH</span><br/>
<span style="font-size:10pt">From the U.S. Government Printing Office, <a href="http://www.gpo.gov">www.gpo.gov</a></span><br/><br/>
<!-- documentid:42_283  usckey:420000000028300000000000000000000 currentthrough:20120103 documentPDFPage:504 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER III/Part A/Sec. 283 -->
<!-- itemsortkey:420AASM -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER III-NATIONAL RESEARCH INSTITUTES!@!Part A-National Institutes of Health!@!Sec. 283 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;283. Biennial reports of Director of NIH</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) In general</h4>
<p class="statutory-body">The Director of NIH shall submit to the Congress on a biennial basis a report in accordance with this section. The first report shall be submitted not later than 1 year after January 15, 2007. Each such report shall include the following information:</p>
<p class="statutory-body-1em">(1) An assessment of the state of biomedical and behavioral research.</p>
<p class="statutory-body-1em">(2) A description of the activities conducted or supported by the agencies of the National Institutes of Health and policies respecting the programs of such agencies.</p>
<p class="statutory-body-1em">(3) Classification and justification for the priorities established by the agencies, including a strategic plan and recommendations for future research initiatives to be carried out under section 282(b)(7) of this title through the Division of Program Coordination, Planning, and Strategic Initiatives.</p>
<p class="statutory-body-1em">(4) A catalog of all the research activities of the agencies, prepared in accordance with the following:</p>
<p class="statutory-body-2em">(A) The catalog shall, for each such activity&mdash;</p>
<p class="statutory-body-3em">(i) identify the agency or agencies involved;</p>
<p class="statutory-body-3em">(ii) state whether the activity was carried out directly by the agencies or was supported by the agencies and describe to what extent the agency was involved; and</p>
<p class="statutory-body-3em">(iii) identify whether the activity was carried out through a center of excellence.</p>
<br class="Q04" />
<p class="statutory-body-2em">(B) In the case of clinical research, the catalog shall, as appropriate, identify study populations by demographic variables and other variables that contribute to research on minority health and health disparities.</p>
<p class="statutory-body-2em">(C) Research activities listed in the catalog shall include, where applicable, the following:</p>
<p class="statutory-body-3em">(i) Epidemiological studies and longitudinal studies.</p>
<p class="statutory-body-3em">(ii) Disease registries, information clearinghouses, and other data systems.</p>
<p class="statutory-body-3em">(iii) Public education and information campaigns.</p>
<p class="statutory-body-3em">(iv) Training activities, including&mdash;</p>
<p class="statutory-body-4em">(I) National Research Service Awards and Clinical Transformation Science Awards;</p>
<p class="statutory-body-4em">(II) graduate medical education programs, including information on the number and type of graduate degrees awarded during the period in which the programs received funding under this subchapter;</p>
<p class="statutory-body-4em">(III) investigator-initiated awards for postdoctoral training and postdoctoral training funded through research grants;</p>
<p class="statutory-body-4em">(IV) a breakdown by demographic variables and other appropriate categories; and</p>
<p class="statutory-body-4em">(V) an evaluation and comparison of outcomes and effectiveness of various training programs.</p>
<br class="Q04" />
<p class="statutory-body-3em">(v) Clinical trials, including a breakdown of participation by study populations and <!-- PDFPage:505 -->demographic variables and such other information as may be necessary to demonstrate compliance with section 289a&ndash;2 of this title (regarding inclusion of women and minorities in clinical research).</p>
<p class="statutory-body-3em">(vi) Translational research activities with other agencies of the Public Health Service.</p>
<br class="Q04" />
<p class="statutory-body-1em">(5) A summary of the research activities throughout the agencies, which summary shall be organized by the following categories, where applicable:</p>
<p class="statutory-body-2em">(A) Cancer.</p>
<p class="statutory-body-2em">(B) Neurosciences.</p>
<p class="statutory-body-2em">(C) Life stages, human development, and rehabilitation.</p>
<p class="statutory-body-2em">(D) Organ systems.</p>
<p class="statutory-body-2em">(E) Autoimmune diseases.</p>
<p class="statutory-body-2em">(F) Genomics.</p>
<p class="statutory-body-2em">(G) Molecular biology and basic science.</p>
<p class="statutory-body-2em">(H) Technology development.</p>
<p class="statutory-body-2em">(I) Chronic diseases, including pain and palliative care.</p>
<p class="statutory-body-2em">(J) Infectious diseases and bioterrorism.</p>
<p class="statutory-body-2em">(K) Minority health and health disparities.</p>
<p class="statutory-body-2em">(L) Such additional categories as the Director determines to be appropriate.</p>
<br class="Q04" />
<p class="statutory-body-1em">(6) A review of each entity receiving funding under this subchapter in its capacity as a center of excellence (in this paragraph referred to as a &ldquo;center of excellence&rdquo;), including the following:</p>
<p class="statutory-body-2em">(A) An evaluation of the performance and research outcomes of each center of excellence.</p>
<p class="statutory-body-2em">(B) Recommendations for promoting coordination of information among the centers of excellence.</p>
<p class="statutory-body-2em">(C) Recommendations for improving the effectiveness, efficiency, and outcomes of the centers of excellence.</p>
<p class="statutory-body-2em">(D) If no additional centers of excellence have been funded under this subchapter since the previous report under this section, an explanation of the reasons for not funding any additional centers.</p>
<h4 class="subsection-head">(b) Requirement regarding disease-specific research activities</h4>
<p class="statutory-body">In a report under subsection (a), the Director of NIH, when reporting on research activities relating to a specific disease, disorder, or other adverse health condition, shall&mdash;</p>
<p class="statutory-body-1em">(1) present information in a standardized format;</p>
<p class="statutory-body-1em">(2) identify the actual dollar amounts obligated for such activities; and</p>
<p class="statutory-body-1em">(3) include a plan for research on the specific disease, disorder, or other adverse health condition, including a statement of objectives regarding the research, the means for achieving the objectives, a date by which the objectives are expected to be achieved, and justifications for revisions to the plan.</p>
<h4 class="subsection-head">(c) Additional reports</h4>
<p class="statutory-body">In addition to reports required by subsections (a) and (b), the Director of NIH or the head of a national research institute or national center may submit to the Congress such additional reports as the Director or the head of such institute or center determines to be appropriate.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(July 1, 1944, ch. 373, title IV, &sect;403, as added Pub. L. 109&ndash;482, title I, &sect;104(a)(3), Jan. 15, 2007, 120 Stat. 3689; amended Pub. L. 110&ndash;85, title XI, &sect;1104(3), Sept. 27, 2007, 121 Stat. 975.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:priorprovisions-note -->
<h4 class="note-head">Prior Provisions</h4>
<p class="note-body">A prior section 283, act July 1, 1944, ch. 373, title IV, &sect;403, as added Pub. L. 99&ndash;158, &sect;2, Nov. 20, 1985, 99 Stat. 826; amended Pub. L. 100&ndash;607, title I, &sect;112, Nov. 4, 1988, 102 Stat. 3052, required a biennial report by the Director to the President and Congress, prior to repeal by Pub. L. 109&ndash;482, title I, &sect;104(a)(3), Jan. 15, 2007, 120 Stat. 3689.</p>
<!-- field-end:priorprovisions-note -->
<!-- field-start:amendment-note -->
<h4 class="note-head">Amendments</h4>
<p class="note-body"><b>2007</b>&mdash;Subsec. (a)(4)(C)(iv)(III). Pub. L. 110&ndash;85 inserted &ldquo;and postdoctoral training funded through research grants&rdquo; before semicolon at end.</p>
<!-- field-end:amendment-note -->
<!-- field-start:effectivedate-note -->
<h4 class="note-head">Effective Date</h4>
<p class="note-body">Section applicable only with respect to amounts appropriated for fiscal year 2007 or subsequent fiscal years, see section 109 of Pub. L. 109&ndash;482, set out as an Effective Date of 2007 Amendment note under section 281 of this title.</p>
<!-- field-end:effectivedate-note -->
<!-- field-end:notes -->


</body></html>